Novavax | NVAX - SCHULD

Aktienkurs
8.12
Täglich Wechseln
-0.42 -4.92%
Monatlich
-24.81%
Jährlich
38.57%
Q2 Prognose
7.90




SCHULD Veränderung Datum
Adma Biologics USD 83.12M 702K 2025-09
Agenus USD 35.54M 2.34M 2025-03
AstraZeneca USD 32.63B 207M 2025-09
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
Cassava Sciences USD 0 0 2024-12
Geron USD 121.92M 73K 2025-09
GlaxoSmithKline GBP 17.75B 396M 2025-09
MannKind USD 119.91M 73.09M 2025-09
Merck USD 41.37B 5.97B 2025-09
Minerva Neurosciences USD 0 0 2024-09
Moderna USD 734M 7M 2025-09
Novartis USD 32.02B 615M 2025-09
Novavax USD 233.31M 4.23M 2024-09
Pfizer USD 60.85B 78M 2025-09
Sanofi EUR 21.76B 530M 2025-09
Sarepta Therapeutics USD 1.25B 103.69M 2025-09
TG Therapeutics USD 245.34M 8.38M 2025-09